Identification of a Functional Site on CD36 Involved in the Interaction Between Platelets and Collagen.

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Platelet adhesion to exposed collagen initiates the formation of a haemostatic plug after vascular injury.
• Glycoprotein CD36 (also known as GPIIIb/GPIV) is implicated in mediating platelet interactions with collagen.

Purpose of the Study:

• To pinpoint the specific structural and functional sites on Glycoprotein CD36 involved in collagen binding.
• To investigate the role of these sites in collagen-induced platelet aggregation and secretion.

Main Methods:

• Synthesis of eight peptides representing putative hydrophilic regions of CD36 using Fmoc chemistry.
• Testing peptide inhibition of collagen-induced platelet aggregation and secretion in washed platelets.
• Assessing peptide effects on thrombin- and ADP-induced aggregation.
• Evaluating peptide interference with the binding of labeled CD36 to collagen.
• Comparing peptide efficacy with monoclonal antibodies in platelet-rich plasma.

Main Results:

• Peptide E5 (residues 415-427) significantly inhibited collagen-induced platelet aggregation and secretion in washed platelets.
• Peptide E5 did not affect aggregation induced by thrombin or ADP.
• Peptide E5 demonstrated interference with the binding of CD36 to collagen.
• Peptide E5 showed limited impact on collagen-induced aggregation in platelet-rich plasma.

Conclusions:

• Peptide E5 identifies a critical site on CD36 responsible for collagen interaction.
• This CD36-collagen interaction site plays a role in specific platelet functions, particularly in washed platelet conditions.
• Findings contribute to understanding the molecular mechanisms of platelet adhesion and haemostasis.